The invention relates to compounds of general formula (I): wherein R 1 , R 2 , R 3 , R 10 and X − are as defined herein. The compounds are inhibitors of the epithelial sodium channel (ENaC) and are useful for the treatment or prevention respiratory diseases and conditions.